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The Epstein-Barr virus immediate-early protein BZLF1 is a transcriptional activator that mediates the
switch from latent to lytic infection. Here we demonstrate that BZLF1 induces both a G2 block and a mitotic
block in HeLa cells and inhibits chromosome condensation. While the G2 block is associated with decreased
cyclin B1 in host cells and can be rescued by overexpression of cyclin B1, the mechanism for the mitotic defect
is as yet undetermined.
Epstein-Barr virus (EBV) is a gamma herpesvirus that
infects approximately 85% of the population. EBV causes
infectious mononucleosis and is also associated with naso-
pharyngeal carcinoma, Burkitt’s lymphoma, Hodgkin’s dis-
ease, and B-cell lymphomas in immunocompromised pa-
tients (25, 34). The EBV immediate-early protein BZLF1 is
a transcriptional activator which binds to Ap1-like motifs in
the promoters of early lytic viral genes and induces the
switch from the latent to lytic life cycle in EBV (5, 7, 13, 36,
41).
Many viruses manipulate the host cell environment, in
particular cell cycle progression, as a mechanism to enhance
viral replication (39). Small DNA tumor viruses push cells
into the S phase (38), while herpesviruses have been found
to arrest cells in all phases of the cell cycle (8, 11, 22, 27, 37,
38). The cell cycle effects of herpesviruses are commonly
mediated by the immediate-early proteins (20, 22, 26, 30, 46,
47). In the case of EBV, although BZLF1 expression in
HeLa cells was reported to induce primarily a G1/G0 block,
expression in U-2 OS cells induced a G2/M block (3, 4). In
addition, when the Burkitt’s lymphoma cell line Rael was
induced into the lytic form of EBV infection using azacyti-
dine, the BZLF1-positive subset of cells appeared to be
blocked in the G2/M component of the cell cycle (35). How-
ever, the mechanism(s) by which BZLF1 induces a G2/M
block in certain cell types have not been previously explored,
nor is it known whether BZLF1 induces a G2 block, a mitotic
block, or both.
The effect of BZLF1 expression on cell cycle progression in
various cell types was examined using an adenovirus vector
expressing BZLF1 (AdBZLF1) constructed as previously de-
scribed (44). Cells were either mock infected, infected with
AdLacZ (a control adenovirus vector expressing LacZ), or
infected with AdBZLF1 at a titer equal to that of AdLacZ.
Cells were harvested at various time points after infection and
processed for cell cycle analysis as previously described (40).
We have demonstrated that the cellular level of BZLF1 ex-
pression in HeLa cells infected with AdBZLF1 at a multiplicity
of infection (MOI) of 50 is similar to that in the lytically
infected population of EBV-positive gastric carcinoma AGS
cells (29).
Although Cayrol and Flemington reported that BZLF1 ex-
pression using a plasmid vector in HeLa cells induced primarily
a G1/S block (3, 4), we found that infection of HeLa cells with
the AdBZLF1 vector resulted in primarily a G2/M block (Fig.
1). In contrast, infection of asynchronously growing normal
human fibroblasts with the AdBZLF1 vector induced both a
G1/S block and a G2/M block (Fig. 2). These results indicate
that BZLF1 expression induces a G2/M block in at least some
cell types.
To further define the mechanism(s) by which BZLF1 ex-
pression results in a G2/M block in HeLa cells, we examined
the levels of the cyclin B1 and cdc2 kinase proteins using
immunoblot analysis as previously described (40) using an-
tibodies specific to cyclin B1 and cdc2 (both a gift from Yue
Xiong, University of North Carolina at Chapel Hill). The
progression of cells from G2 to mitosis is orchestrated by
the cyclin-dependent kinase cdc2 and cyclin B1 (32).
BZLF1 expression in HeLa cells reduced the level of the
cyclin B1 protein markedly (Fig. 3A) and, to a lesser extent,
cdc2 (Fig. 3C). We also examined the level of cyclin B1 RNA in
HeLa cells infected with the AdLacZ or AdBZLF1 vector
(Fig. 3B). Northern blot analysis was performed as previ-
ously described (29) using a randomly primed 32P-labeled
DNA probe containing the cyclin B1 sequence. AdBZLF1-
infected HeLa cells had a greatly reduced cyclin B1 tran-
script level compared to AdLacZ-infected cells, while a con-
trol transcript, glyceraldehyde-3-phosphate dehydrogenase,
was unaffected. These results suggest that BZLF1 reduces
cyclin B1 at least partially at the RNA level, either by de-
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creasing transcription or decreasing the stability of the cy-
clin B1 message.
cdc2 activity is inhibited when the protein is phosphorylated
at two specific sites (threonine 14 and tyrosine 15) (9). Al-
though BZLF1-expressing HeLa cells had less total cdc2 than
AdLacZ-infected cells, most of the protein appeared to be in
the active (unphosphorylated) form (Fig. 3C). Extracts from
cells treated with nocodazole (which blocks cells in mitosis)
served as a control for the dephosphorylated form of cdc2. The
level of a control cellular protein, -actin, was not affected by
FIG. 1. BZLF1 causes a G2/M block in HeLa cells. Cells were mock infected or infected with the AdLacZ or AdBZLF1 vector (MOI of 50).
Cell cycle was examined at various time points after infection by quantitating both bromodeoxyuridine (BrdU) incorporation and propidium iodine
staining as previously described (40) using FACS analysis and a BrdU antibody.
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BZLF1. These results suggest that BZLF1 induces a G2 block
in HeLa cells by decreasing the level of cyclin B1, as well as
possibly cdc2.
To confirm that the cdc2- and cyclin B1-associated ki-
nase activities are reduced in BZLF1-expressing HeLa cells,
we performed immunoprecipitations of the AdLacZ- and
AdBZLF1-infected HeLa cell extracts using a control anti-
body or cyclin B1 and cdc2 antibodies, and examined the
FIG. 2. BZLF1 causes both a G1/G0 block and a G2/M block in normal human fibroblasts. Normal human fibroblasts were infected with the
AdLacZ or AdBZLF1 vector using an MOI of 250, which produces a level of cellular BZLF1 expression similar to that produced by an MOI of
50 in HeLa cells (data not shown). The cell cycle stage was determined at various time points after infection.
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ability of the immunoprecipitated proteins to phosphorylate
the histone H1 substrate as previously described (10) (Fig.
3D). Extracts from HeLa cells treated with colcemid (which
blocks cells in mitosis) served as a positive control in these
experiments. Both the cyclin B1- and cdc2-associated kinase
activities were greatly reduced in the AdBZLF1-infected
HeLa cells compared to the AdLacZ-infected cells.
To determine whether the G2/M block in BZLF1-expressing
HeLa cells is due to the lack of cyclin B1, HeLa cells were
infected with the AdBZLF1 and AdLacZ vectors in the pres-
ence or absence of adenovirus vectors expressing cyclin B1 (a
generous gift from David Morgan (23). One of these vectors
expresses wild-type cyclin B1 (AdCyclinB), while the other
expresses cyclin B1 fused to the simian virus 40 (SV40) nuclear
localization signal (AdCyclinBNLS), allowing constitutive nu-
clear targeting of cyclin B1 independent of the cell cycle (23).
Cells were first infected for 24 h with either the AdBZLF1 or
AdLacZ vector and subsequently infected for an additional
24 h with either the AdLacZ or cyclin B vector. As shown in
Fig. 4A, coinfection of HeLa cells with AdBZLF1 and either of
the cyclin B1 vectors did not affect the number of cells in G2/M
compared to infection with AdBZLF1 alone. However, since
overexpression of cyclin B1 is known to induce a mitotic block
(16, 21, 31), this effect may obscure its ability to rescue the
BZLF1-induced G2 block unless the G2 and mitotic compart-
ments are individually examined.
Therefore, in the same experiment, we also examined the
number of BZLF1-positive cells that had phosphorylation of
histone H3 over serine 10 (a marker for early mitosis) (17) in
the presence and absence of overexpressed cyclin B (Fig. 4B).
The number of cells within the G2/M compartment of the cell
cycle with phosphorylated histone H3 was quantitated by flu-
orescence-activated cell sorting (FACS) analysis as previously
described (24) using an antibody that specifically recognizes
histone H3 phosphorylated over serine 10 (catalog no. 06-570;
Upstate Biotechnology), combined with propidium iodine
staining. HeLa cells infected with AdBZLF1 alone had a lower
number of G2/M cells with histone H3 phosphorylation than
the AdLacZ-infected cells, and this effect was reversed by
subsequent infection with the cyclin B adenovirus vectors. Im-
munoblot analysis of the same experiment (Fig. 4C) indicated
that less cyclin B protein (both endogenous cyclin B and cyclin
B derived from the adenovirus vectors) was present in cells
infected with the BZLF1 vector versus cells infected with the
AdLacZ vector. Since expression of cyclin B in the adenovirus
vectors is driven by a heterologous promoter, BZLF1 may thus
decrease cyclin B RNA stability (and possibly protein stability
as well), rather than transcription.
To confirm that cyclin B reverses the BZLF1-induced G2
block, the percentage of total mitotic cells in two independent
experiments was quantitated using propidium iodide staining
in HeLa cells infected with the AdLacZ vector, the cyclin
B1 vectors, the AdBZLF1 vector, or various combinations of
these vectors (Fig. 4D). In comparison to cells infected with
AdLacZ, HeLa cells expressing BZLF1 alone had fewer cells
in mitosis (3 versus 8%), again suggesting that BZLF1 primar-
ily induces a G2, rather than a mitotic, block in this cell type.
When cells were coinfected with AdBZLF1 and either of the
cyclin B1 vectors, the number of cells in mitosis was increased
compared to cells infected with AdBZLF1 alone, particularly
in the case of the AdCyclinBNLS construct. Thus, it appears
that the G2 block caused by BZLF1 can be reversed by
reconstituting cyclin B1 expression. However, the mitotic
block caused by overexpression of cyclin B1 alone did not
allow us to assess the effect of BZLF1 on mitosis in these
experiments.
To further examine the effect of BZLF1 on mitosis in HeLa
cells and normal human fibroblasts, the chromosomes in
AdLacZ-infected and AdBZLF1-infected cells were examined
as previously described using Giemsa staining (14). As shown
in Fig. 5, in both of these cell types, the AdBZLF1-infected
cells, but not the AdLacZ-infected cells, had a substantial
number of cells in which mitosis appeared to be blocked due to
a defect in chromosomal condensation and detangling. This
defect was observed in 44% of the total metaphase population
in BZLF1-infected normal human fibroblasts compared to only
FIG. 3. BZLF1 decreases cyclin B1. HeLa cells were mock in-
fected or infected with the AdLacZ vector or the AdBZLF1 vector.
Two days postinfection, whole-cell extracts and RNA were pre-
pared. (A) Immunoblot analysis was performed using an antibody
against cyclin B1. (B) Northern blot analysis was performed using
probes directed against cyclin B1 or glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). (C) Immunoblot analysis was performed
to quantitate the expression and phosphorylation status of cdc2.
Cells were also treated with aphidicolin and nocodazole, which
block cells in S phase and M phase, respectively. Cdc2-p, phosphor-
ylated cdc2. (D) Cyclin B1- and cdc2-associated kinase activity was
quantitated as previously described (10) by immunoprecipitating
(IP) extracts with cdc2 or cyclin B1 antibodies as indicated and then
performing kinase assays using a histone H1 substrate. No AB, no
antibodies.
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4% of the total metaphase population in AdLacZ-infected
normal human fibroblasts. Similar results were obtained in
HeLa cells.
In this report we have examined the mechanism(s) by which
the EBV immediate-early protein BZLF1 induces a G2/M
block in HeLa cells. We demonstrate that BZLF1 decreases
the cyclin B1 transcript level, as well as the cyclin B1 protein
level, in HeLa cells. Furthermore, we show that cyclin B1
overexpression reverses the BZLF1-mediated G2 block, sug-
gesting that inhibition of cyclin B1 is the primary mechanism
for this effect. Our results here also document for the first
time that BZLF1 inhibits mitosis in both HeLa cells and nor-
mal human fibroblasts. This mitotic defect, which is character-
ized by incomplete chromosomal condensation and detangling,
is reminiscent of the cell cycle block induced by inhibition of
topoisomerase II (6). The herpes simplex virus ICP0 protein
also induces a mitotic block, although in this case the defect is
characterized by a “pseudoprometaphase” phenotype (12).
Rodriguez et al. previously reported that the lytically in-
fected population of Rael Burkitt’s lymphoma cells has a
higher proportion of cells in G2/M than does the latently in-
fected population (35). Therefore, the results obtained here
using the BZLF1 adenovirus vector in EBV-negative cells may
be relevant to the cell cycle effects occurring during authentic
lytic EBV infection in some cell types. Although our results
here clearly show that BZLF1 induces a G2/M block in certain
FIG. 4. Cyclin B1 overexpression reverses the G2 block in AdBZLF1-infected HeLa cells. HeLa cells were infected with AdLacZ or AdBZLF1
or with an adenovirus vector expressing wild-type cyclin B1 (AdCyclinB) or cyclin B1 fused to the SV40 nuclear localization signal (AdCyclinBNLS)
in the combinations indicated. (A) Cell cycle analysis was performed 2 days after infection as described in the legend to Fig. 1. (B) The number
of cells in very early mitosis (in the same experiment shown in panel A) was quantitated by FACS analysis using an antibody directed against
phosphorylated histone H3 (serine 10), combined with propidium iodine staining (to identify the G2/M compartment). A total of 28,000 cells were
examined for each condition, and the total number of cells in very early mitosis for each condition is shown. (C) Immunoblot analysis was
performed on cell extracts to quantitate the relative level of cyclin B in each condition. The adenovirus cyclin B proteins have lower mobility due
to an epitope tag (23). (D) The percentages of cells specifically in mitosis in each condition from two separate experiments (average and range)
were calculated as previously described (14).
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cell types, the BZLF1 cell cycle effects appear to be cell type
dependent (A. Mauser, E. Holley-Guthrie, A. Zanation, W.
Yarborough, W. Kaufmann, A. Klingelhutz, and S. Kenney,
unpublished data). Interestingly, we recently found that
BZLF1 expression in telomerase-immortalized keratinocytes
actually enhances expression of some S-phase-specific proteins
(Mauser et al., unpublished), and the EBV-induced lesion, oral
hairy leukoplakia, which contains the lytic form of EBV infec-
tion, appears to be a hyperproliferative lesion (43). Therefore,
blocking the host cell cycle may be more advantageous for
EBV lytic replication in some cell types.
Similar to the effect of lytic EBV infection, infection of some
cell types with herpes simplex virus type 1 and human cyto-
megalovirus likewise induces a G2/M block which is at least
partially due to the effects of the immediate-early proteins
ICP0 and IE2-86, respectively (1, 2, 22, 26). Interestingly, a
variety of other viral proteins have also been found to induce
a G2/M block, including SV40 small-t antigen (15, 45), human
parvovirus B19 (28), human immunodeficiency virus type 1 vpr
(18, 19, 33), and a vaccinia virus-encoded protein (42). To our
knowledge, BZLF1 is unique among these viral proteins in its
ability to induce a G2 block by decreasing cyclin B1. The
finding that so many different viruses block cells in G2/M sug-
gests that either this stage of the cell cycle is particularly ad-
vantageous for viral replication and/or that inhibition of cellu-
lar DNA replication enhances the ability of some viruses to
replicate.
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